Connection

Yuki Kageyama to Cisplatin

This is a "connection" page, showing publications Yuki Kageyama has written about Cisplatin.
Connection Strength

0.502
  1. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009 Jul; 104(2):189-94.
    View in: PubMed
    Score: 0.072
  2. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors. Int J Urol. 2008 Jul; 15(7):642-5.
    View in: PubMed
    Score: 0.069
  3. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008 Aug; 72(2):384-8.
    View in: PubMed
    Score: 0.068
  4. Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer. Am J Clin Oncol. 2003 Oct; 26(5):504-7.
    View in: PubMed
    Score: 0.050
  5. [Neoadjuvant chemotherapy for invasive bladder cancer]. Gan To Kagaku Ryoho. 2001 Nov; 28(12):1838-44.
    View in: PubMed
    Score: 0.044
  6. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients. Jpn J Clin Oncol. 2000 Dec; 30(12):553-6.
    View in: PubMed
    Score: 0.041
  7. Advanced testicular germ cell tumor in a hemophilic patient with human immunodeficiency virus infection. Jpn J Clin Oncol. 1998 Sep; 28(9):567-70.
    View in: PubMed
    Score: 0.035
  8. Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience. Int J Clin Oncol. 2013 Aug; 18(4):731-4.
    View in: PubMed
    Score: 0.023
  9. [Result of treatment for advanced germ cell tumor in the last decade]. Nihon Hinyokika Gakkai Zasshi. 2010 Mar; 101(3):539-46.
    View in: PubMed
    Score: 0.019
  10. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008 Apr; 101(8):978-81.
    View in: PubMed
    Score: 0.017
  11. [Bladder preservation by chemoradiotherapy in combination with radical TUR-Bt in muscle invasive bladder cancer]. Nihon Hinyokika Gakkai Zasshi. 2007 Sep; 98(6):752-6.
    View in: PubMed
    Score: 0.016
  12. Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases. Int J Urol. 2007 May; 14(5):455-7.
    View in: PubMed
    Score: 0.016
  13. Late relapse of stage I testicular seminoma metastatic to just a para-ureteropelvic region. Int J Urol. 2004 Nov; 11(11):1044-6.
    View in: PubMed
    Score: 0.013
  14. [Experience with induction chemoradiotherapy for cT4N2M0 lung cancer]. Kyobu Geka. 2000 Mar; 53(3):239-41.
    View in: PubMed
    Score: 0.010
  15. [High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) For advanced testicular cancer]. Hinyokika Kiyo. 1998 May; 44(5):313-8.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.